REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
SERATEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SERATEC
ST13
US500000079250594Class
5, 9, 10
Filing
79250594
Registration
6430382
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
07/27/2026
Trademark type
Word
Nice classes
5, 9, 10
Filing date
08/28/2018
Registration date
07/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
ERVIN, INGA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. M. (pessoa física)
Representatives
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
In vitro diagnostic preparations for medical purposes; in vitro diagnostic agents for medical purposes; in vitro diagnostics for forensic purposes; medical diagnostic reagents used in immunochromatographic quick tests; clinical medical reagentsreagents for clinical-chemical tests; medical diagnostic test strips for the examination of food and foodstuffs; medical diagnostic test strips for conducting immunochromatographic tests; medical diagnostic test strips for conducting chemical tests; medical test kit comprised primarily of diagnostic preparations for detecting body fluids; medical test kit comprised primarily of diagnostic preparations for determining body fluids; medical test kit comprised primarily of diagnostic preparations for detecting substances in body fluids; drug testing kits comprised of medical diagnostic reagents and assays for testing substances in body fluids; medical test kit comprised primarily of diagnostic preparations for quantifying substances in body fluids; pregnancy test kits for home use; ovulation test kits; medical diagnostic test strips for PSA analysis; haemoglobin tests for medical purposes; medical test kit comprised primarily of diagnostic preparations for detecting human haemoglobin; medical test kit comprised primarily of diagnostic preparations for detecting saliva; medical test kit comprised primarily of diagnostic preparations for detecting seminal fluid; reagents for medical use; clinical medical reagents for forensic use; clinical medical reagents for conducting immunochromatographic tests; clinical medical reagents for conducting chemical tests; immunoassay reagents for medical use; clinical medical immunoassay reagents for forensic use; clinical medical immunoassay reagents for conducting immunochromatographic tests; clinical medical immunoassay reagents for conducting chemical tests; diagnostic kits consisting primarily of medical antibodies; diagnostic kits consisting primarily of antibodies for forensic purposes; diagnostic kits consisting primarily of antibodies for conducting immunochromatographic tests
Class 9
Downloadable computer software for computersmobile phonessmartphonestabletsPDAs and other mobile electronic devices for the presentationanalysismonitoring and storage of medical test results; downloadable computer software for computersmobile phonessmartphonestabletsPDAs and other mobile electronic devices for the presentationanalysismonitoring and storage of test results relating to drug testspregnancy testsovulation tests and/or PSA tests
Class 10
Medical diagnostic apparatusanalytical apparatus for medical purposes; medical diagnostic testing apparatus for forensic purposes; medical diagnostic testing apparatus for immunochromatography; medical diagnostic testing apparatus for detecting body fluids; medical diagnostic testing apparatus for determining body fluids; medical diagnostic testing apparatus for detecting substances in body fluids; medical diagnostic testing apparatus for determining substances in body fluids; medical diagnostic testing apparatus for quantifying substances in body fluids; medical diagnostic testing apparatus for detecting drugs; medical diagnostic testing apparatus for identifying drugs; medical diagnostic testing apparatus for quantifying a drug in a body fluid; medical diagnostic testing apparatus for detecting PSA; medical diagnostic testing apparatus for quantifying PSA in a body fluid; medical diagnostic testing apparatus for diagnosis of pregnancy; medical diagnostic testing apparatus for diagnosis of ovulation; medical diagnostic testing apparatus for detecting haemoglobin; medical diagnostic testing apparatus for detecting saliva; medical diagnostic testing apparatus for detecting seminal fluid
Publications
History of USPTO decisions and trademark events.
59 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/01/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/09/2021
FIMP
FINAL DISPOSITION PROCESSED
12/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/11/2021
PUBO
PUBLISHED FOR OPPOSITION
05/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/21/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/24/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2021
GNRT
NON-FINAL ACTION E-MAILED
02/23/2021
CNRT
NON-FINAL ACTION WRITTEN
02/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/19/2021
GNRT
NON-FINAL ACTION E-MAILED
01/19/2021
CNRT
NON-FINAL ACTION WRITTEN
01/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/20/2020
GNRT
NON-FINAL ACTION E-MAILED
10/20/2020
CNRT
NON-FINAL ACTION WRITTEN
10/20/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/15/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/08/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/02/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/20/2020
ALIE
ASSIGNED TO LIE
01/30/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/08/2019
GNSL
LETTER OF SUSPENSION E-MAILED
07/08/2019
CNSL
SUSPENSION LETTER WRITTEN
07/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2019
CNRT
NON-FINAL ACTION MAILED
06/06/2019
CNRT
NON-FINAL ACTION WRITTEN
06/06/2019
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
05/15/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/29/2019
RFNT
REFUSAL PROCESSED BY IB
03/16/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/23/2019
RFRR
REFUSAL PROCESSED BY MPU
02/23/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/16/2019
CNRT
NON-FINAL ACTION WRITTEN
02/15/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/09/2019
DOCK
ASSIGNED TO EXAMINER
02/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/04/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/31/2019
Continuous trademark protection
Get notified about every new filing that threatens SERATEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.